Search results
Results from the WOW.Com Content Network
Tandem Diabetes Care interviewed more than 4,000 insulin pump users and health care providers to design its first device, the t:slim Insulin Pump. [6] In 2016, the company was ranked #39 on the Deloitte Fast 500 North America list. [7] In 2018, the company was recognized as a top workplace in San Diego by the San Diego Union-Tribune. [8]
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide ...
Canagliflozin is indicated to be used with diet and exercise to lower blood sugar in adults with type 2 diabetes; to reduce the risk of major heart-related events such as heart attack, stroke, or death in people with type 2 diabetes who have known heart disease; and to reduce the risk of end-stage kidney disease, worsening of kidney function, heart-related death, and being hospitalized for ...
This $127 device concentrates sodium ions on the tongue, making low-sodium foods taste up to 1.5 times saltier. The spoon offers four adjustable intensity levels, ranging from mild (yellow light ...
GSK filed for US FDA approval on 14 January 2013 and for European Medicines Agency (EMA) approval on 7 March 2013. In March 2014, GSK received approval from the European Commission to market albiglutide under the name Eperzan. [11] In April 2014, the US FDA approved albiglutide under the name Tanzeum. [12]
Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is approved for treating obesity. Both are made by Novo Nordisk. Both are made by Novo Nordisk. ‘Yo-yo’ Weight Loss ...
The drugs were approved as additions to diet and exercise to improve blood sugar control in children aged 10 years and above with type 2 diabetes, the most common form of the disease. The ...
Similar in size, shape and thickness to a postage stamp, thin-film strips are typically designed for oral administration, with the user placing the strip on or under the tongue (sublingual) or along the inside of the cheek (buccal). These drug delivery options allow the medication to bypass the first pass metabolism thereby making the ...